With reported performance validation on over 17,000 ultrasound images, Sonio Detect employs artificial intelligence (AI) to help ensure quality criteria for fetal ultrasound imaging of the brain and heart.
The Food and Drug Administration (FDA) has granted 510(k) clearance for Sonio Detect (Sonio), a fetal ultrasound software as a service (SaaS) platform that utilizes artificial intelligence (AI) to enhance the assessment of fetal heart and brain structures.
Emphasizing Sonio Detect’s robust accuracy in identifying ultrasound views and quality criteria, Sonio said the technology demonstrated a 92 percent sensitivity in performance validation testing on over 17,000 ultrasound images.
Sonio claimed the technology with Sonio Detect increases the efficiency of fetal heart and brain assessment and may facilitate improved diagnosis of fetal anomalies.
“Bringing the first easy to use, manufacturer agnostic and efficient quality control solution to all OBGYNs, (maternal fetal medicine specialists) and sonographers, we believe better screening will lead to better detection of potential anomalies or reassurance to provide better maternal care. Our goal is to transform prenatal care by providing a reliable tool that ensures better health outcomes for both mothers and babies,” noted Cecile Brosset, the chief executive officer and co-founder of Sonio.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.